Research: constituent Literature Activity scores (blend; no single score)
Data as of Nov 17, 2026 · Sources: Wikipedia pageviews, Reddit, X public mentions.
Measures online attention only. It is not a measure of quality, purity, efficacy, or safety.
Publications per year
This catalog item is a multi-constituent blend, so there is no honest single-compound PubMed corpus and no publications-per-year chart. Literature Activity is not scored.
This catalog item is a two-constituent blend. There is no honest single-compound PubMed corpus for the finished product, so Literature Activity is not scored and there is no publications-per-year chart. Cards below are constituent literature, clearly labeled as not studies of this blend.
Key specifications
Catalog facts are taken from the live PEPTIDEA™ listing. Formula and molecular weight are from PubChem. Sequence is omitted here.
Catalog title
RC-BPTB4 | Tissue Signaling Research
Research focus
Tissue Signaling Research
Also described as
Multi-constituent blend of BPC-157 and TB-500 / thymosin beta-4. Ratio not stated.
Format
Lyophilized research peptide blend
Catalog status
In stock (public listing)
Presentations
10, 20, and 30 mg vialsCatalog sizes, not a protocol
Molecular formula
No single PubChem recordBlend; formula is not assigned
Molecular weight
Not listed as a single massBlend; mass is not assigned
Receptor context
Multi-constituent blend; see constituent pages for receptor contextCatalog identity only
Sequence
Not reproduced hereSee primary literature / PubChem
Researcher access
Sign-in required to view pricing
Catalog notes & use limitations
Research-catalog framing only. This section does not describe effects in people or study outcomes.
Catalog notes
Listed under Tissue Signaling Research
RC-BPTB4 appears in the PEPTIDEA™ Cellular Signaling Research collection with the single-compound listings RC-BPC and RC-TB4 and with the four-constituent listing RC-KLW.
Multi-constituent blend; amounts not stated
Named constituents are BPC-157 and TB-500 / thymosin beta-4. This page lists those names for identity only and does not present amounts or ratios. The TB-500 name may refer to full-length thymosin beta-4 or to a shorter fragment; this page does not assign one sequence to the blend.
No blend-level PubMed corpus
Literature cards below are studies or reviews of named constituents, or of a laboratory combination that is not this catalog item. They are not trials of this finished blend.
10, 20, and 30 mg catalog presentations
The public listing is a variable product with 10 mg, 20 mg, and 30 mg size attributes. The default control on this page is the 10 mg presentation. Catalog sizes are not a protocol.
Use limitations
Research use only
Not for human or veterinary use. Not a drug, not a cosmetic, and not medical advice. Not presented here as a treatment or weight-management product.
No outcome or dosing information
This page does not list administration amounts, schedules, or clinical results. Catalog vial sizes are presentations of the research material, not a protocol.
Confirm details from primary sources
Formula and molecular weight are cited from PubChem when a single compound applies; otherwise see the catalog notes. Sequence is omitted. Read the original papers for laboratory context — results stay in the original publications.
Specifications
Laboratory-catalog and public-chemistry details. Items without a cited source are marked.
Catalog title
RC-BPTB4 | Tissue Signaling Research
Category
Tissue Signaling Research (Cellular Signaling Research)
Associated names
Named constituents: BPC-157 and TB-500 / thymosin beta-4. Amounts, ratio, and the exact TB-500 sequence are not stated on this page.
Format
Lyophilized research peptide blend
Public catalog status
In stock (as of Nov 17, 2026)
Catalog presentations
10, 20, and 30 mg vials — sizes of the research material, not a use protocol
Molecular formula
No single PubChem record (Blend; formula is not assigned, retrieved Nov 17, 2026)
Molecular weight
Not listed as a single mass (Blend; mass is not assigned)
InChIKey
Not listed as a single InChIKey (PubChem)
Receptor context
Handbook notes identify the named constituents as BPC-157 and TB-500 / thymosin beta-4. This page lists those names for identity only and does not present amounts, ratios, or a single receptor description as facts about the finished blend.
Sequence
Not reproduced on this page. See primary literature and the PubChem record.
Pricing
Visible after researcher sign-in
No PubChem CID is assigned to the finished blend.
Research literature
These are Peptidea-written summaries of selected publications, prepared so you can stay on peptidea.net. Each card describes what was studied — the research question, study type, and mechanism or setting. We do not restate results, endpoints, or protocols. Full papers remain with their publishers; a small PubMed source link is included only for citation.
Review — constituent (BPC-157), not the blend
Seiwerth et al.
Frontiers in Pharmacology · 2021
BPC 157 described as a stable gastric pentadecapeptide
This paper studied materials named BPC-157 and TB-500 together in a rat Achilles-tendon model. The paper itself refers to TB-500 as “synthetic thymosin beta-4.” This page does not adopt that equation or assign a TB-500 sequence or ratio to this vial, and the paper is not a study of this finished catalog blend.
Wound-healing and other applied wording in the review is not restated on this page.
Review — constituent (thymosin beta-4), not the blend
Ying et al.
Current Protein and Peptide Science · 2023
Thymosin beta-4 and actin-binding biochemistry
This review surveys thymosin beta-4 as an actin-binding peptide. It is included because TB-500 / thymosin beta-4 is a named constituent of this blend, not because the review studied the blend. Findings for full-length Tβ4 cannot automatically be applied to a shorter fragment.
Clinical-application wording in the review is not reproduced here.
Experimental, animal model — constituent (BPC-157), not the blend
Staresinic et al.
Journal of Orthopaedic Research · 2003
BPC 157 in a transected rat Achilles-tendon model and cultured tendocytes
This paper studied BPC 157 in a transected rat Achilles-tendon model and in cultured tendocytes. It is included because BPC-157 is a named constituent of this blend, not because the paper studied the blend. A large share of this literature comes from a single research tradition.
Healing-model and cell-culture findings in the paper are not restated on this page.
Experimental, animal model — named combination, not this catalog blend
Biçer et al.
Joint Diseases and Related Surgery · 2026
A rat Achilles-tendon model that names both BPC-157 and TB-500
This paper studied materials named BPC-157 and TB-500 together in a rat Achilles-tendon model. It is included as combination-context literature only. It is not a study of this finished catalog blend, and it does not establish the ratio or the TB-500 sequence of this vial.
Histopathology, biomechanics, and any other findings in the paper are not reproduced here.
General laboratory-catalog guidance for layout purposes. Always follow the vial label and your institution’s written procedures.
Handle as a lyophilized research material intended for laboratory use only.
Store according to the conditions printed on the label and in any compound document provided to approved researchers.
Protect closed vials from moisture and unnecessary temperature swings.
If reconstitution is performed, use only the laboratory’s own written procedures. This page does not provide volumes, solvents, or working concentrations.
This material is not for human or veterinary use and is not medical advice.
No dosing, administration, or protocol instructions are included on this page.
Related compounds
Other PEPTIDEA™ materials currently listed under Tissue Signaling Research on the public catalog.